Selected research
Industry Research
Antiretroviral Therapy Industry Research Report 2026
Market perspective
The global Antiretroviral Therapy market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Antiretroviral Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Antiretroviral Therapy is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Antiretroviral Therapy is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Antiretroviral Therapy include Janssen Pharmaceuticals, Mylan, Abbvie, ViiV Healthcare, Vertex Pharmaceuticals, Gilead, F. Hoffmann-La Roche, Boehringer Ingelheim and Bionor Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Antiretroviral Therapy market in terms of revenue (US$ million) and, where applicable, sales volume (Kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Antiretroviral Therapy Market by Company
Janssen Pharmaceuticals
Mylan
Abbvie
ViiV Healthcare
Vertex Pharmaceuticals
Gilead
F. Hoffmann-La Roche
Boehringer Ingelheim
Bionor Pharma
Antiretroviral Therapy Segment by Type
Integrase Inhibitors
NRTI
NNRTIs
Multiclass Combination Products
Antiretroviral Therapy Segment by Application
Hospital
Clinic
Other
Antiretroviral Therapy Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antiretroviral Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Antiretroviral Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antiretroviral Therapy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Antiretroviral Therapy manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Antiretroviral Therapy by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Antiretroviral Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Integrase Inhibitors
- NRTI
- NNRTIs
- Multiclass Combination Products
Applications
- Hospital
- Clinic
- Other
Companies covered
- Janssen Pharmaceuticals
- Mylan
- Abbvie
- ViiV Healthcare
- Vertex Pharmaceuticals
- Gilead
- F. Hoffmann-La Roche
- Boehringer Ingelheim
- Bionor Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Antiretroviral Therapy Market Size (2021-2032)
- 2.2.2 Global Antiretroviral Therapy Sales (2021-2032)
- 2.2.3 Global Antiretroviral Therapy Market Average Price (2021-2032)
- 2.3 Antiretroviral Therapy by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Integrase Inhibitors
- 2.3.3 NRTI
- 2.3.4 NNRTIs
- 2.3.5 Multiclass Combination Products
- 2.4 Antiretroviral Therapy by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Antiretroviral Therapy Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Antiretroviral Therapy Sales (Kg) of Manufacturers (2021-2026)
- 3.3 Global Antiretroviral Therapy Revenue of Manufacturers (2021-2026)
- 3.4 Global Antiretroviral Therapy Average Price by Manufacturers (2021-2026)
- 3.5 Global Antiretroviral Therapy Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Antiretroviral Therapy, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Antiretroviral Therapy, Product Type & Application
- 3.8 Global Manufacturers of Antiretroviral Therapy, Established Date
- 3.9 Global Antiretroviral Therapy Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Janssen Pharmaceuticals
- 4.1.1 Janssen Pharmaceuticals Company Information
- 4.1.2 Janssen Pharmaceuticals Business Overview
- 4.1.3 Janssen Pharmaceuticals Antiretroviral Therapy Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Janssen Pharmaceuticals Antiretroviral Therapy Product Portfolio
- 4.1.5 Janssen Pharmaceuticals Recent Developments
- 4.2 Mylan
- 4.2.1 Mylan Company Information
- 4.2.2 Mylan Business Overview
- 4.2.3 Mylan Antiretroviral Therapy Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Mylan Antiretroviral Therapy Product Portfolio
- 4.2.5 Mylan Recent Developments
- 4.3 Abbvie
- 4.3.1 Abbvie Company Information
- 4.3.2 Abbvie Business Overview
- 4.3.3 Abbvie Antiretroviral Therapy Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Abbvie Antiretroviral Therapy Product Portfolio
- 4.3.5 Abbvie Recent Developments
- 4.4 ViiV Healthcare
- 4.4.1 ViiV Healthcare Company Information
- 4.4.2 ViiV Healthcare Business Overview
- 4.4.3 ViiV Healthcare Antiretroviral Therapy Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 ViiV Healthcare Antiretroviral Therapy Product Portfolio
- 4.4.5 ViiV Healthcare Recent Developments
- 4.5 Vertex Pharmaceuticals
- 4.5.1 Vertex Pharmaceuticals Company Information
- 4.5.2 Vertex Pharmaceuticals Business Overview
- 4.5.3 Vertex Pharmaceuticals Antiretroviral Therapy Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Vertex Pharmaceuticals Antiretroviral Therapy Product Portfolio
- 4.5.5 Vertex Pharmaceuticals Recent Developments
- 4.6 Gilead
- 4.6.1 Gilead Company Information
- 4.6.2 Gilead Business Overview
- 4.6.3 Gilead Antiretroviral Therapy Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Gilead Antiretroviral Therapy Product Portfolio
- 4.6.5 Gilead Recent Developments
- 4.7 F. Hoffmann-La Roche
- 4.7.1 F. Hoffmann-La Roche Company Information
- 4.7.2 F. Hoffmann-La Roche Business Overview
- 4.7.3 F. Hoffmann-La Roche Antiretroviral Therapy Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 F. Hoffmann-La Roche Antiretroviral Therapy Product Portfolio
- 4.7.5 F. Hoffmann-La Roche Recent Developments
- 4.8 Boehringer Ingelheim
- 4.8.1 Boehringer Ingelheim Company Information
- 4.8.2 Boehringer Ingelheim Business Overview
- 4.8.3 Boehringer Ingelheim Antiretroviral Therapy Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Boehringer Ingelheim Antiretroviral Therapy Product Portfolio
- 4.8.5 Boehringer Ingelheim Recent Developments
- 4.9 Bionor Pharma
- 4.9.1 Bionor Pharma Company Information
- 4.9.2 Bionor Pharma Business Overview
- 4.9.3 Bionor Pharma Antiretroviral Therapy Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Bionor Pharma Antiretroviral Therapy Product Portfolio
- 4.9.5 Bionor Pharma Recent Developments
5 Global Antiretroviral Therapy Market Scenario by Region
- 5.1 Global Antiretroviral Therapy Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Antiretroviral Therapy Sales by Region: 2021-2032
- 5.2.1 Global Antiretroviral Therapy Sales by Region: 2021-2026
- 5.2.2 Global Antiretroviral Therapy Sales by Region: 2027-2032
- 5.3 Global Antiretroviral Therapy Revenue by Region: 2021-2032
- 5.3.1 Global Antiretroviral Therapy Revenue by Region: 2021-2026
- 5.3.2 Global Antiretroviral Therapy Revenue by Region: 2027-2032
- 5.4 North America Antiretroviral Therapy Market Facts & Figures by Country
- 5.4.1 North America Antiretroviral Therapy Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Antiretroviral Therapy Sales by Country (2021-2032)
- 5.4.3 North America Antiretroviral Therapy Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Antiretroviral Therapy Market Facts & Figures by Country
- 5.5.1 Europe Antiretroviral Therapy Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Antiretroviral Therapy Sales by Country (2021-2032)
- 5.5.3 Europe Antiretroviral Therapy Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Antiretroviral Therapy Market Facts & Figures by Country
- 5.6.1 Asia Pacific Antiretroviral Therapy Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Antiretroviral Therapy Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Antiretroviral Therapy Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Antiretroviral Therapy Market Facts & Figures by Country
- 5.7.1 South America Antiretroviral Therapy Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Antiretroviral Therapy Sales by Country (2021-2032)
- 5.7.3 South America Antiretroviral Therapy Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Antiretroviral Therapy Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Antiretroviral Therapy Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Antiretroviral Therapy Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Antiretroviral Therapy Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Antiretroviral Therapy Sales by Type (2021-2032)
- 6.1.1 Global Antiretroviral Therapy Sales by Type (2021-2032) & (Kg)
- 6.1.2 Global Antiretroviral Therapy Sales Market Share by Type (2021-2032)
- 6.2 Global Antiretroviral Therapy Revenue by Type (2021-2032)
- 6.2.1 Global Antiretroviral Therapy Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Antiretroviral Therapy Revenue Market Share by Type (2021-2032)
- 6.3 Global Antiretroviral Therapy Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Antiretroviral Therapy Sales by Application (2021-2032)
- 7.1.1 Global Antiretroviral Therapy Sales by Application (2021-2032) & (Kg)
- 7.1.2 Global Antiretroviral Therapy Sales Market Share by Application (2021-2032)
- 7.2 Global Antiretroviral Therapy Revenue by Application (2021-2032)
- 7.2.1 Global Antiretroviral Therapy Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Antiretroviral Therapy Revenue Market Share by Application (2021-2032)
- 7.3 Global Antiretroviral Therapy Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Antiretroviral Therapy Value Chain Analysis
- 8.1.1 Antiretroviral Therapy Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Antiretroviral Therapy Production Mode & Process
- 8.2 Antiretroviral Therapy Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Antiretroviral Therapy Distributors
- 8.2.3 Antiretroviral Therapy Customers
9 Global Antiretroviral Therapy Analyzing Market Dynamics
- 9.1 Antiretroviral Therapy Industry Trends
- 9.2 Antiretroviral Therapy Industry Drivers
- 9.3 Antiretroviral Therapy Industry Opportunities and Challenges
- 9.4 Antiretroviral Therapy Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst